TrumpRx Officially Launches With Promise To Dramatically Cut Drug Costs For Americans

President Donald Trump on Thursday officially launched the federal government’s highly anticipated direct-to-consumer medication website called TrumpRx. The site, which Trump lauded as a major win for his administration, will give Americans access to big discounts on popular and high-priced medicines. Now, consumers can pay low prices that are comparable to other developed nations, keeping ...
--
President Donald Trump on Thursday officially launched the federal government’s highly anticipated direct-to-consumer medication website called TrumpRx.

The site, which Trump lauded as a major win for his administration, will give Americans access to big discounts on popular and high-priced medicines. Now, consumers can pay low prices that are comparable to other developed nations, keeping in line with the Trump Most-Favored Nation policy.

“America was being overcharged for medicine. The same drugs, made in the same factories, at the same dosages, are costing Americans up to 1,000% more than in any other country,” the live TrumpRx site reads. “This is unacceptable.”

“Starting tonight, dozens of the most commonly used prescription drugs will be available at dramatic discounts for all consumers throughout our new website, it’s called TrumpRx.gov,” the president announced at Thursday’s launch.

“For years, politicians from both parties have promised to bring down prescription drug prices and make health care more affordable, but they all failed. It was all words, as usual,” he added. “But I’m actually getting it done; it is done, actually.”

🚨 @POTUS: “Starting tonight, dozens of the most commonly-used prescription drugs will be available at dramatic discounts for all consumers throughout a new website: https://t.co/QSJ4wskHM1.” pic.twitter.com/tB9FdIZMWZ

— Rapid Response 47 (@RapidResponse47) February 6, 2026

According to the White House, Trump was able to make deals with major companies like AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk, and Pfizer to get the lower drug prices for Americans.

“Additional drugs from other companies that have signed MFN pricing deals will be made available through TrumpRx.gov in the coming months,” a press release said, adding, “Depending on the manufacturer of a given drug, patients with valid prescriptions will be able to access savings through user-friendly coupons that can be printed or downloaded onto their phones or through channels set up by the manufacturer and integrated into TrumpRx.gov.”

Screenshot: Trump RX

A White House fact-sheet sent to The Daily Wire listed the following examples of reduced-price medications:

The monthly prices of Ozempic and injectable Wegovy will fall from $1,028 and $1,349, respectively, to an average price of $350 and as low as $199, depending on dosage strength.

The monthly price of the Wegovy pill will fall from $1,349 to as low as $149, depending on dosage strength.

The monthly price of Zepbound will fall from $1,088 to an average price of $346 and as low as $299, depending on dosage strength.

Gonal-F, one of the most commonly-used fertility drugs, will see its price reduced to as low as $168 per pen, depending on dosage strength.

The price of Cetrotide, another commonly used fertility medicine, will drop from $316 to $22.50.

The price of Ovidrel will fall from $251 to $84.

Bevespi Aerosphere, an inhaler used to treat chronic obstructive pulmonary disease (COPD), will be discounted from $458 to $51.

Airsupra, an inhaler used to treat asthma symptoms and attacks, will see a price drop from $504 to $201.

Eucrisa, a topical ointment for atopic dermatitis, will be discounted from $792 to $158.

Insulin Lispro will be available for as low as $25 per month.

Duavee, a medication used to treat hot flashes and osteoporosis, will see its price cut from $202 to $30.

America’s HealthShare (AHS), a popular health sharing ministry, praised the development from the administration.

“America’s healthcare system is broken, and people are simply paying too much for medicine and hospital visits. America’s HealthShare enthusiastically supports the effort to offer working families and elderly people on fixed incomes access to more affordable prescription drugs,” America’s HealthShare President David Lejeune said in a statement sent to The Daily Wire.

“Our law and policy makers can and should work with this Administration, in bipartisan fashion, to address long-term solutions to America’s healthcare system,” he added. “At America’s HealthShare, we are proud to support the Make America Healthy Again movement by restoring freedom and accountability in healthcare through an innovative approach.”